In this episode, we critically evaluate the expanding clinical profile of brexpiprazole, analyzing its recent FDA approval for agitation in Alzheimer’s dementia alongside the data behind its rejection for PTSD. We dive into perinatal mental health with Dr. Amritha Bhat, who offers expert guidance on navigating the risk-benefit analysis of psychotropics during pregnancy, the use of zuranolone, and first-line management for postpartum psychosis. Listeners will also discover new consensus guidelines that recommend prescribing metformin concurrently with high-risk antipsychotics to prevent metabolic side effects. We round out the discussion with recent research updates on the dose-dependent antidepressant effects of Vitamin D and the efficacy of service dogs for veterans. These evidence-based insights are essential for psychiatric nurse practitioners ai ...